State-of-the-art, fully licensed cannabis manufacturing facility in North Macedonia is available for purchase. This low-cost manufacturing, EU-GMP-compliant facility is strategically positioned to capitalize on the growing global medicinal cannabis market, and has access to established supply chains and contracts.
Key Highlights:
Facility & Land:
- 2,500 m² EU-GMP-compliant pharmaceutical facility for manufacturing, R&D, processing, and packaging.
- 25 acres of commercial land owned; 5 acres licensed for production (greenhouse/indoor) and outdoor cultivation.
- Capacity for tolling 1,000 kg of dried flower per month (GACP to GMP), extraction of 130 liters per month, and internal cultivation of 100 kg per month. Outdoor cultivation potential exceeds 4,000 kg annually.
- Includes packaging, white-labeling capabilities, finished product production, and stability chambers.
- Additional urban planning and taxes paid for a future 13,000 m² expansion, adding €100m+ annual capacity.
Production Capacity:
- Current capacity for over €20m annual production.
- Growing €18m pipeline with diversified supply agreements and multiple LOIs/contracts.
Strategic Position:
- Exclusive contract with a UK FDA Botanical Pathway Drug Development company.
- Established relationships with clinics, distributors, universities, and partners in the UK, Poland, Germany, and Australia.
- Positioned as a gateway for cannabis import/export across Europe, with potential to pioneer cannabinoid-based medication and technology globally.
Financial Incentives:
- Two local government grants, R&D tax rebates, 10% corporation tax, and 26% CAPEX rebate.
- Local bank lending support.
Team & Expertise:
- EU-GMP-trained team with expertise spanning medical, pharmaceuticals, technology, and cannabinoids.
Investment Opportunity:
- Asking Price: €6,950,000 for the wholly owned land, facility, licenses, and going-concern business.
- Option to lease licensed land parcel or acquire additional cannabinoid/IP assets from the UK parent company.
This certified cannabis facility provides an opportunity to own a fully licensed, EU-GMP-compliant cannabis manufacturing and cultivation operation with significant growth potential.
